8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) November 12, 2007

ICU Medical, Inc.
(Exact name of registrant as specified in its charter)

DELAWARE	0-19974	33-0022692
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

951 Calle Amanecer, San Clemente, California	92673
(Address of principal executive offices)	(Zip Code)

Registrant's telephone number, including area code:   (949) 366-2183

________________________________________________________________________________
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
	[   ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	[   ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	[   ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	[   ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01. Regulation FD Disclosure.

ICU Medical, Inc. announced its completion of a stock purchase program.

Item 9.01. Financial Statements and Exhibits.

(c)        Exhibits

99.1 Press release, dated November 12, 2007 announcing ICU Medical, Inc.'s completion of a stock purchase program.

SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ICU Medical, Inc. (Registrant)
November 13, 2007 (Date)	/s/   FRANCIS J. O'BRIEN Francis J. O'Brien Secretary, Treasurer and Chief Financial Officer

EX-99.1

EXHIBIT 99.1

ICU Medical, Inc. Announces Completion of a Stock Purchase Program

SAN CLEMENTE, Calif., Nov. 12, 2007 (PRIME NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leading low cost manufacturer of safe medical connectors, custom medical products and critical care devices, announced that it has completed a program announced in September 2007 to purchase up to $20 million of its common stock. Under that program 516,565 shares were purchased at a cost of $20 million.

Total purchases in 2007 under the September 2007 and earlier programs total 1,062,922 shares at a cost of $41 million. This brings the outstanding shares down to 13,681,950. The Company currently does not have another stock purchase program in place. Actual future purchases will depend on the stock price, prevailing market and business conditions and other considerations.

The foregoing statement concerning Management's expectation with respect to future purchases of its stock is a forward-looking statement based upon the best information currently available to Management and assumptions Management believes are reasonable, but Management does not intend the statement to be a representation as to future results. Future results are subject to risks and uncertainties, which include the risk factors described in the Company's filings with the Securities and Exchange Commission, which include those in the Form 10-K for the year ended December 31, 2006 and the Form 10-Q for the quarter ended September 30, 2007. Actual results in the future may differ materially from Management's current expectations.

CONTACT:  ICU Medical, Inc.
          Francis J. O'Brien, Chief Financial Officer
          (949) 366-2183

          Integrated Corporate Relations
          John F. Mills, Managing Director
          (310) 395-2215